๐๐๐๐๐ฅ๐ข๐ง๐: ๐๐๐ฏ๐ข๐ ๐๐ญ๐ข๐ง๐ ๐๐ ๐๐ข๐ฌ๐ค ๐ข๐ง ๐๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐: ๐๐ญ ๐๐ญ๐๐ซ๐ญ๐ฌ ๐ฐ๐ข๐ญ๐ก ๐ ๐ ๐ซ๐๐ฆ๐๐ฐ๐จ๐ซ๐ค ๐๐ ๐๐ง๐ ๐๐๐๐ก๐ข๐ง๐ ๐๐๐๐ซ๐ง๐ข๐ง๐ ๐๐ซ๐ ๐ญ๐ซ๐๐ง๐ฌ๐๐จ๐ซ๐ฆ๐ข๐ง๐ ๐ฆ๐๐๐ข๐๐๐ฅ ๐๐๐ฏ๐ข๐๐๐ฌ, ๐จ๐๐๐๐ซ๐ข๐ง๐ ๐ข๐ง๐๐ซ๐๐๐ข๐๐ฅ๐ ๐ฉ๐จ๐ญ๐๐ง๐ญ๐ข๐๐ฅ ๐๐จ๐ซ ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ข๐ฌ, ๐ญ๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ, ๐๐ง๐ ๐ฉ๐๐ญ๐ข๐๐ง๐ญ ๐๐๐ซ๐. ๐๐ฎ๐ญ ๐ฐ๐ข๐ญ๐ก ๐ญ๐ก๐ข๐ฌ ๐ฉ๐จ๐ฐ๐๐ซ ๐๐จ๐ฆ๐๐ฌ ๐ ๐๐ซ๐ข๐ญ๐ข๐๐๐ฅ ๐ช๐ฎ๐๐ฌ๐ญ๐ข๐จ๐ง: ๐๐จ๐ฐ ๐๐จ ๐ฐ๐ ๐๐ง๐ฌ๐ฎ๐ซ๐ ๐ญ๐ก๐๐ฌ๐ “๐๐ฅ๐๐๐ค ๐๐จ๐ฑ” ๐ฌ๐ฒ๐ฌ๐ญ๐๐ฆ๐ฌ ๐๐ซ๐ ๐ฌ๐๐๐ ๐๐ง๐ ๐๐๐๐๐๐ญ๐ข๐ฏ๐? ๐๐ง๐ญ๐๐ซ ๐๐๐๐ ๐๐๐๐๐๐๐๐. ๐๐ก๐ข๐ฌ ๐๐๐๐ก๐ง๐ข๐๐๐ฅ ๐๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง ๐๐๐ฉ๐จ๐ซ๐ญ […]
Archive for December 12th, 2025
๐๐๐ฏ๐ข๐ ๐๐ญ๐ข๐ง๐ ๐๐ ๐๐ข๐ฌ๐ค ๐ข๐ง ๐๐๐๐ฅ๐ญ๐ก๐๐๐ซ๐: ๐๐ญ ๐๐ญ๐๐ซ๐ญ๐ฌ ๐ฐ๐ข๐ญ๐ก ๐ ๐ ๐ซ๐๐ฆ๐๐ฐ๐จ๐ซ๐ค
Posted by Michael A. S. Guth on December 12th, 2025
The Dosing Diet: PK/PD Lessons from the Incretin Revolution
Posted by Michael A. S. Guth on December 12th, 2025
The pharmaceutical landscape is being rapidly reshaped by a class of drugs known as incretin mimetics, particularly the new generation of anti-obesity medications (AOMs). While the public focuses on the dramatic weight loss achieved by agonists like semaglutide and tirzepatide, the true marvel of these therapeutics lies in their precise Pharmacokinetics (PK) and Pharmacodynamics (PD).ย These […]



Posted in